Literature DB >> 23944318

Current and future therapies for hepatitis C virus infection.

Marc G Ghany, T Jake Liang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23944318      PMCID： PMC3878654          DOI： 10.1056/NEJMc1307589

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

Review 1.  Current and future therapies for hepatitis C virus infection.

Authors:  T Jake Liang; Marc G Ghany
Journal:  N Engl J Med       Date:  2013-05-16       Impact factor: 91.245
  1 in total
  14 in total

Review 1.  Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.

Authors:  Fang Liu; Chunfang Wang; Yuantao Gao; Xiao Li; Feng Tian; Yongtao Zhang; Mingyang Fu; Pengfei Li; Yali Wang; Fei Wang
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

2.  Rising Trends in Emergency Department Visits Associated With Hepatitis C Virus Infection in the United States, 2006-2014.

Authors:  Shaoman Yin; Laurie Barker; Eyasu H Teshale; Ruth B Jiles
Journal:  Public Health Rep       Date:  2019-10-02       Impact factor: 2.792

3.  Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During Direct-Acting Antiviral Therapy.

Authors:  Hawwa Alao; Maggie Cam; Chithra Keembiyehetty; Fang Zhang; Elisavet Serti; Daniel Suarez; Heiyoung Park; Nicolaas H Fourie; Elizabeth C Wright; Wendy A Henderson; Qisheng Li; T Jake Liang; Barbara Rehermann; Marc G Ghany
Journal:  Hepatology       Date:  2018-07-16       Impact factor: 17.425

4.  Undiagnosed HIV and HCV Infection in a New York City Emergency Department, 2015.

Authors:  Lucia V Torian; Uriel R Felsen; Qiang Xia; Fabienne Laraque; Eric J Rude; Herbert Rose; Adam Cole; Angelica Bocour; Gary J Williams; Robert F Bridgforth; Lisa A Forgione; Howard Doo; Sarah L Braunstein; Demetre C Daskalakis; Barry S Zingman
Journal:  Am J Public Health       Date:  2018-03-22       Impact factor: 9.308

5.  Entry Inhibitors of Hepatitis C Virus.

Authors:  Xi-Jing Qian; Zhong-Tian Qi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies.

Authors:  Johnathan Zhang; Douglas Nguyen; Ke-Qin Hu
Journal:  N Am J Med Sci (Boston)       Date:  2016-04-27

Review 7.  Finding a cure for human immunodeficiency virus-1 infection.

Authors:  Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  Infect Dis Clin North Am       Date:  2014-09-30       Impact factor: 5.982

8.  Demographic profile, host, disease & viral predictive factors of response in patients with chronic hepatitis C virus infection at a tertiary care hospital in north India.

Authors:  Sreejith Vasudevan; Amit Kavimandan; Nancy Kalra; Baibaswata Nayak; Bhaskar Thakur; Prasenjit Das; Siddhartha Datta Gupta; Subrat Kumar Panda; Subrat Kumar Acharya
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

Review 9.  Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection.

Authors:  Alireza FakhriRavari; Mazyar Malakouti; Rebecca Brady
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

Review 10.  Spotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis C.

Authors:  Duminda Suraweera; Ashley N Weeratunga; Sammy Saab
Journal:  Drug Des Devel Ther       Date:  2016-06-29       Impact factor: 4.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.